Biblio

Export 876 results:
Author Title [ Type(Desc)] Year
Filters: Keyword is Humans  [Clear All Filters]
Journal Article
E. M. Khedr, Omeran, N., Ramadan, H. Karam- Alla, Ahmed, G. K., and Abdelwarith, A. M., Alteration of Gut Microbiota in Alzheimer's Disease and Their Relation to the Cognitive Impairment., J Alzheimers Dis, vol. 88, no. 3, pp. 1103-1114, 2022.
H. - H. Tsou, Hsu, W. - C., Fuh, J. - L., Chen, S. - P., Liu, T. - Y., and Wang, H. - T., Alterations in Acrolein Metabolism Contribute to Alzheimer's Disease., J Alzheimers Dis, vol. 61, no. 2, pp. 571-580, 2018.
S. Yamashita, Kiko, T., Fujiwara, H., Hashimoto, M., Nakagawa, K., Kinoshita, M., Furukawa, K., Arai, H., and Miyazawa, T., Alterations in the Levels of Amyloid-β, Phospholipid Hydroperoxide, and Plasmalogen in the Blood of Patients with Alzheimer's Disease: Possible Interactions between Amyloid-β and These Lipids., J Alzheimers Dis, vol. 50, no. 2, pp. 527-37, 2016.
P. Joussain, Bessy, M., Fournel, A., Ferdenzi, C., Rouby, C., Delphin-Combe, F., Krolak-Salmon, P., and Bensafi, M., Altered Affective Evaluations of Smells in Alzheimer's Disease., J Alzheimers Dis, vol. 49, no. 2, pp. 433-41, 2016.
C. Saraceno, Catania, M., Paterlini, A., Fostinelli, S., Ciani, M., Zanardini, R., Binetti, G., Di Fede, G., Caroppo, P., Benussi, L., Ghidoni, R., and Bolognin, S., Altered Expression of Circulating Cdc42 in Frontotemporal Lobar Degeneration., J Alzheimers Dis, vol. 61, no. 4, pp. 1477-1483, 2018.
C. N. Clark, Nicholas, J. M., Gordon, E., Golden, H. L., Cohen, M. H., Woodward, F. J., Macpherson, K., Slattery, C. F., Mummery, C. J., Schott, J. M., Rohrer, J. D., and Warren, J. D., Altered sense of humor in dementia., J Alzheimers Dis, vol. 49, no. 1, pp. 111-9, 2016.
M. Lardelli, An Alternative View of Familial Alzheimer's Disease Genetics., J Alzheimers Dis, vol. 96, no. 1, pp. 13-39, 2023.
A. Noori, Jayakumar, R., Moturi, V., Li, Z., Liu, R., Serrano-Pozo, A., Hyman, B. T., and Das, S., Alzheimer DataLENS: An Open Data Analytics Portal for Alzheimer's Disease Research., J Alzheimers Dis, vol. 99, no. s2, pp. S397-S407, 2024.
P. J. Lao, Handen, B. L., Betthauser, T. J., Mihaila, I., Hartley, S. L., Cohen, A. D., Tudorascu, D. L., Bulova, P. D., Lopresti, B. J., Tumuluru, R. V., Murali, D., Mathis, C. A., Barnhart, T. E., Stone, C. K., Price, J. C., Devenny, D. A., Johnson, S. C., Klunk, W. E., and Christian, B. T., Alzheimer-Like Pattern of Hypometabolism Emerges with Elevated Amyloid-β Burden in Down Syndrome., J Alzheimers Dis, vol. 61, no. 2, pp. 631-644, 2018.
C. Grobler, van Tongeren, M., Gettemans, J., Kell, D. B., and Pretorius, E., Alzheimer's Disease: A Systems View Provides a Unifying Explanation of Its Development., J Alzheimers Dis, vol. 91, no. 1, pp. 43-70, 2023.
R. Gil and Arroyo-Anlló, E. M., Alzheimer's Disease and Face Masks in Times of COVID-19., J Alzheimers Dis, vol. 79, no. 1, pp. 9-14, 2021.
U. Rüb, Stratmann, K., Heinsen, H., Seidel, K., Bouzrou, M., and Korf, H. - W., Alzheimer's Disease: Characterization of the Brain Sites of the Initial Tau Cytoskeletal Pathology Will Improve the Success of Novel Immunological Anti-Tau Treatment Approaches., J Alzheimers Dis, vol. 57, no. 3, pp. 683-696, 2017.
A. Aljassabi, Zieneldien, T., Kim, J., Regmi, D., and Cao, C., Alzheimer's Disease Immunotherapy: Current Strategies and Future Prospects., J Alzheimers Dis, vol. 98, no. 3, pp. 755-772, 2024.
K. C Kim, Lee, Y. Rui, Ong, L., Gold, M., Kalali, A., and Sarkar, J., Alzheimer's Disease: Key Insights from Two Decades of Clinical Trial Failures., J Alzheimers Dis, vol. 87, no. 1, pp. 83-100, 2022.
R. H. Swerdlow, The Alzheimer's Disease Mitochondrial Cascade Hypothesis: A Current Overview., J Alzheimers Dis, vol. 92, no. 3, pp. 751-768, 2023.
R. C. Petersen, Aisen, P. S., Beckett, L. A., Donohue, M. C., Gamst, A. C., Harvey, D. J., Jack, C. R., Jagust, W. J., Shaw, L. M., Toga, A. W., Trojanowski, J. Q., and Weiner, M. W., Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization., Neurology, vol. 74, no. 3, pp. 201-9, 2010.
C. Ferrari, Lombardi, G., Polito, C., Lucidi, G., Bagnoli, S., Piaceri, I., Nacmias, B., Berti, V., Rizzuto, D., Fratiglioni, L., and Sorbi, S., Alzheimer's Disease Progression: Factors Influencing Cognitive Decline., J Alzheimers Dis, vol. 61, no. 2, pp. 785-791, 2018.
D. Zádori, Veres, G., Szalárdy, L., Klivenyi, P., and Vecsei, L., Alzheimer's Disease: Recent Concepts on the Relation of Mitochondrial Disturbances, Excitotoxicity, Neuroinflammation, and Kynurenines., J Alzheimers Dis, vol. 62, no. 2, pp. 523-547, 2018.
A. Griciuc, Serrano-Pozo, A., Parrado, A. R., Lesinski, A. N., Asselin, C. N., Mullin, K., Hooli, B., Choi, S. Hoon, Hyman, B. T., and Tanzi, R. E., Alzheimer's disease risk gene CD33 inhibits microglial uptake of amyloid beta., Neuron, vol. 78, no. 4, pp. 631-43, 2013.
G. Liu, Zhang, Y., Wang, L., Xu, J., Chen, X., Bao, Y., Hu, Y., Jin, S., Tian, R., Bai, W., Zhou, W., Wang, T., Han, Z., Zong, J., and Jiang, Q., Alzheimer's Disease rs11767557 Variant Regulates EPHA1 Gene Expression Specifically in Human Whole Blood., J Alzheimers Dis, vol. 61, no. 3, pp. 1077-1088, 2018.
H. Tong, Petyuk, V. A., Sendtner, M., Sood, A., Bennett, D. A., Capuano, A. W., and Arvanitakis, Z., Alzheimer's disease-related cortical proteins modify the association of brain insulin signaling with cognitive decline., J Alzheimers Dis, vol. 104, no. 3, pp. 667-677, 2025.
H. M. Lalive, Griffa, A., Carlier, S., Nasuti, M., Di Noto, T., Maréchal, B., Rouaud, O., and Allali, G., Amnestic Syndrome in Memory Clinics: Similar Morphological Brain Patterns in Older Adults with and without Alzheimer's Disease., J Alzheimers Dis, vol. 100, no. 1, pp. 333-343, 2024.
K. Noorda, Noorda, K., Sabbagh, M. N., Bertelson, J., Singer, J., and Decourt, B., Amyloid-Directed Antibodies: Past, Present, and Future., J Alzheimers Dis, vol. 101, no. s1, pp. S3-S22, 2024.
S. Hatashita and Wakebe, D., Amyloid-β Deposition and Long-Term Progression in Mild Cognitive Impairment due to Alzheimer's Disease Defined with Amyloid PET Imaging., J Alzheimers Dis, vol. 57, no. 3, pp. 765-773, 2017.
I. Ferrer, Amyloid-β Pathology Is the Common Nominator Proteinopathy of the Primate Brain Aging., J Alzheimers Dis, vol. 100, no. s1, pp. S153-S164, 2024.

Pages